Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Diseases

  Free Subscription

Articles published in Gastroenterology

Retrieve available abstracts of 256 articles:
HTML format

Single Articles

    May 2024
  1. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.

  2. NIEMI NM, Debosch BJ
    Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
    Gastroenterology. 2024;166:936-937.

  3. GEORGE B, Kudryashova O, Kravets A, Thalji S, et al
    Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
    Gastroenterology. 2024;166:859-871.
    PubMed     Abstract available

  4. SCHONAUER R, Sierks D, Boerrigter M, Jawaid T, et al
    Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
    Gastroenterology. 2024;166:902-914.
    PubMed     Abstract available

    April 2024
  5. WANG L, Berger NA, Kaelber DC, Xu R, et al
    Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes.
    Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
    PubMed     Abstract available

  6. JIANG C, Lian M, Ma X
    A Rare Case Mimicking Congenital Hepatic Fibrosis.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00483.

    March 2024
  7. CAMPANI C, Guido M, Marra F
    Elusive hepatic nodules.
    Gastroenterology. 2024 Mar 23:S0016-5085(24)00355.

  8. HOLTZ LR, DeBosch BJ
    Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
    Gastroenterology. 2024;166:534-535.

  9. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
    PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
    Gastroenterology. 2024;166:515-517.

  10. GAO F, Seto WK, Zheng MH
    Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
    Gastroenterology. 2024;166:541-542.

  11. AN T, Liu L, Li X
    Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
    Gastroenterology. 2024;166:540-541.

    February 2024
  12. WONG RJ, Yang Z, Cheung R, Singal AK, et al
    Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
    Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
    PubMed     Abstract available

  13. CHEN J, Feng W, Sun M, Huang W, et al
    TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
    Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
    PubMed     Abstract available

  14. ALLEN AM, Pose E, Reddy KR, Russo MW, et al
    Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges.
    Gastroenterology. 2024;166:229-234.

  15. WALAYAT S, Pfau P
    2 AM in the Intensive Care Unit: What Could Go Wrong?
    Gastroenterology. 2024;166:e13-e15.

  16. BILAL M, Steinberg J, Louissaint J, Phan J, et al
    First Year on the Job as a Gastroenterologist and Hepatologist: Lessons Learned.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00125.

    January 2024
  17. POSE E, Piano S, Juanola A, Gines P, et al
    Gastroenterology. 2024 Jan 19:S0016-5085(24)00054.
    PubMed     Abstract available

  18. LAURIDSEN MM, Gronkjaer LL, Khraibut S, Patel N, et al
    The multi-dimensional challenge of poor oral health in cirrhosis - disparities and solutions.
    Gastroenterology. 2024 Jan 13:S0016-5085(24)00043.

    Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?
    Gastroenterology. 2024;166:213-214.

  20. ZENG Q, Wu D, Tang H
    A Mysterious Abdominal Pain.
    Gastroenterology. 2024;166:27-30.

    December 2023
  21. MEZZACAPPA C, Bhat M
    Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests?
    Gastroenterology. 2023;165:1576.

    November 2023
  22. GARCIA-TSAO G, Abraldes JG, Rich NE, Wong VW, et al
    AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Gastroenterology. 2023 Nov 17:S0016-5085(23)05143.
    PubMed     Abstract available

  23. KOJIMA H, Kadono K, Hirao H, Dery KJ, et al
    T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans.
    Gastroenterology. 2023;165:1233-1248.
    PubMed     Abstract available

  24. PENA-SANCHEZ JN, Osei JA, Teucher U, Tremblay M, et al
    Working With Indigenous Community and Patient Partners Is Essential to Advance Gastroenterology and Hepatology Research: Perspectives From Canada.
    Gastroenterology. 2023;165:1097-1101.

  25. LLOVET JM, Heikenwalder M
    Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology.
    Gastroenterology. 2023;165:1308-1310.

    October 2023
  26. AMPUERO J, Berzigotti A
    Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
    Gastroenterology. 2023;165:829-831.

  27. SEMMLER G, Yang Z, Fritz L, Kock F, et al
    Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
    Gastroenterology. 2023;165:1041-1052.
    PubMed     Abstract available

  28. MAN S, Deng Y, Ma Y, Fu J, et al
    Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
    Gastroenterology. 2023;165:1025-1040.
    PubMed     Abstract available

  29. YIP TC, Fan JG, Wong VW
    China's Fatty Liver Crisis: A Looming Public Health Emergency.
    Gastroenterology. 2023;165:825-827.

  30. TICA S, Debosch BJ
    Bariatric Surgery for the Treatment of NASH-An Old Solution to a Newer Problem?
    Gastroenterology. 2023;165:1091.

  31. WATTACHERIL JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al
    AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2023;165:1080-1088.
    PubMed     Abstract available

    September 2023
  32. CHEN J, Yang Q, Wang C
    Multiple Hepatic Masses in a Patient with Crohn's disease.
    Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.

  33. XIE L, Guo H
    Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the incidence and risk factors of hepatic steatosis and hepatic fibrosis in the Chinese population.
    Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.

    Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination.
    Gastroenterology. 2023 Sep 6:S0016-5085(23)04976.

  35. NEWMAN KL, Velez C, Paul S, Radix AE, et al
    Research Considerations in Digestive and Liver Disease in Transgender and Gender-Diverse Populations.
    Gastroenterology. 2023;165:523-528.

  36. WANG Y, Huang Y, Chase RC, Li T, et al
    Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019.
    Gastroenterology. 2023;165:773-783.
    PubMed     Abstract available

  37. INTAGLIATA NM, Rahimi RS, Higuera-de-la-Tijera F, Simonetto DA, et al
    Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study.
    Gastroenterology. 2023;165:717-732.
    PubMed     Abstract available

  38. ZUO T, Xie Q, Liu J, Yang J, et al
    Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis.
    Gastroenterology. 2023;165:746-761.
    PubMed     Abstract available

  39. FLIGOR SC, Tsikis ST, Hirsch TI, Pan A, et al
    A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.
    Gastroenterology. 2023;165:733-745.
    PubMed     Abstract available

  40. WASSERMAN R, Reddy S, Grider D
    An Unusual Manifestation of Elevated Liver Enzymes and Architecture.
    Gastroenterology. 2023;165:e4-e6.

    August 2023
  41. HUANG DQ, Wilson LA, Behling C, Kleiner DE, et al
    Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
    Gastroenterology. 2023;165:463-472.
    PubMed     Abstract available

    Genomic Analysis of Hair From Celebrated Composer Provides Insight Into Liver Disease Susceptibility.
    Gastroenterology. 2023;165:514.

    Next-Generation Farnesoid X Receptor Agonists in NASH Treatment: Are We There Yet?
    Gastroenterology. 2023;165:513-514.

  44. PENG Z, Li S, Pi R
    A Giant Cystic Liver Mass in an Elderly Man.
    Gastroenterology. 2023;165:e5-e7.

  45. ZHANG XF, Yin ZK, Zhang JY
    An Unusual Case of Intermittent Fever With Multiple Liver Lesions.
    Gastroenterology. 2023;165:e11-e14.

  46. KHAN AA, Turki M, Frandah W
    An Unusual Case of Hematemesis.
    Gastroenterology. 2023;165:e8-e10.

  47. SHEN C, Zhang J, Xia Q
    Unexpected Abdominal Wall Varices After Split-Liver Transplantation.
    Gastroenterology. 2023;165:354-356.

    July 2023
  48. REDDY KR, McLerran D, Marsh T, Parikh N, et al
    Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
    Gastroenterology. 2023 Jul 8:S0016-5085(23)04765.
    PubMed     Abstract available

  49. LO YN, Wu JS, Chiang HC
    A Pseudo-Gastric Bubble.
    Gastroenterology. 2023;165:e16-e18.

  50. LI GF, Yu G
    Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System.
    Gastroenterology. 2023;165:305-306.

    Obeying the Law: Energy Balance in Alternate-Day Fasting, Exercise, or Both Together in Patients With Obesity and NAFLD.
    Gastroenterology. 2023;165:301.

  52. RATZIU V, Friedman SL
    Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
    Gastroenterology. 2023;165:5-10.

    June 2023
  53. NISHIWAKI T, Tsutsumi Y, Nakaji S
    A mysterious hepatic mass.
    Gastroenterology. 2023 Jun 15:S0016-5085(23)00879.

  54. CHINNASAMY V, Sakulsaengprapha V, Mathews SC
    The Benefit of Artificial Intelligence-Based Diagnosis in Gastroenterology and Hepatology is Highly Variable: A Diagnostic Need and Burden Analysis.
    Gastroenterology. 2023 Jun 2:S0016-5085(23)00818.

  55. THIELE M, Suvitaival T, Trost K, Kim M, et al
    Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis.
    Gastroenterology. 2023;164:1248-1260.
    PubMed     Abstract available

  56. SCHEINER B, Pinato DJ
    Tumor-infiltrating Neutrophils: Gatekeepers in Liver Cancer Immune Control.
    Gastroenterology. 2023;164:1338-1339.

    The Impact of Proportional Dietary Carbohydrate and Fat Content on Type 2 Diabetes and NAFLD.
    Gastroenterology. 2023;164:1338.

  58. LIU W, Wei DH, Tong QY
    The Bull's-Eye Sign in Liver: Are They Liver Metastases?
    Gastroenterology. 2023;164:1056-1058.

    May 2023
  59. FARIAS AQ, Vilalta AC, Zitelli PM, Pereira G, et al
    Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America.
    Gastroenterology. 2023 May 30:S0016-5085(23)00806.
    PubMed     Abstract available

  60. YANG XM, Wang XQ, Hu LP, Feng MX, et al
    Nucleolar HEATR1 upregulated by mTORC1 signaling promotes hepatocellular carcinoma growth by dominating ribosome biogenesis and proteome homeostasis.
    Gastroenterology. 2023 May 27:S0016-5085(23)00802.
    PubMed     Abstract available

  61. WANG J, Yu H, Dong W, Zhang C, et al
    N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/beta-Catenin and Hippo Signaling Pathways.
    Gastroenterology. 2023;164:990-1005.
    PubMed     Abstract available

    April 2023
  62. CHO MY, Sung PS, Lee SH
    Multiple Hepatic Artery Pseudoaneurysms with Eosinophilia.
    Gastroenterology. 2023 Apr 26:S0016-5085(23)00629.

  63. HAN H, Ge X, Babu Komakula SS, Desert R, et al
    Gastroenterology. 2023 Apr 5:S0016-5085(23)00581.
    PubMed     Abstract available

  64. GOLDOWSKY A, Ding J, Velez C, Paul S, et al
    Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology.
    Gastroenterology. 2023;164:510-514.

  65. XU X, Alanaeme J, Wen Y, Colantonio LD, et al
    Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population.
    Gastroenterology. 2023;164:688-689.

  66. GADIYARAM S, Nachiappan M
    An Unusual Cause of Lower Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:e4-e7.

    March 2023
  67. EINER C, Munk DE, Park E, Akdogan B, et al
    ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson Disease rats.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00529.
    PubMed     Abstract available

  68. GADIYARAM S, Nachiappan M, Kini D
    Liver SOL in a case of colon cancer, a red herring.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00534.

  69. KO PH, Tseng CW
    An Unusual Cause of Acute Cholecystitis.
    Gastroenterology. 2023 Mar 23:S0016-5085(23)00531.

  70. KUCUKKOSE E, Laoukili J, Gorelick AN, Degner S, et al
    Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer.
    Gastroenterology. 2023 Mar 9:S0016-5085(23)00256.
    PubMed     Abstract available

  71. SAITO Y, Yin D, Kubota N, Wang X, et al
    A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00235.
    PubMed     Abstract available

  72. ESPINOZA M, Muiquith M, Lim M, Zhu H, et al
    Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00234.

  73. YANG S, Qian L, Li Z, Li Y, et al
    Integrated Multi-Omics Landscape of Liver Metastases.
    Gastroenterology. 2023;164:407-423.
    PubMed     Abstract available

  74. NICOLETTI P, Dellinger A, Li YJ, Barnhart HX, et al
    Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
    Gastroenterology. 2023;164:454-466.
    PubMed     Abstract available

  75. SUN J, Debosch B
    Guardian, Intermediary, or Perpetrator? New Insights Into Environmental Exposure, the Gut Microbiome, and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2023;164:492.

  76. SHA M, Tong Y, Cao J
    "Malignant" Liver Lesions in an Incidental But High-Risk Patient.
    Gastroenterology. 2023;164:e17-e19.

  77. LIU R, Dai Z, Zhu C
    A Rare Cause of Liver Fibrosis in an Adolescent Woman.
    Gastroenterology. 2023;164:340-343.

    Use of the Term "Lean" for Nonalcoholic Fatty Liver Disease in Individuals With Low Body Mass Index.
    Gastroenterology. 2023;164:502-503.

  79. TAMBAKIS G, Florescu C, Tsoi E
    Three Lumens Full of Blood-An Unusual Case of Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:334-335.

    February 2023
  80. L'HERMITE S, Bordet M, Rayer C
    A Woman With Recurrent Upper Gastrointestinal Bleeding.
    Gastroenterology. 2023 Feb 18:S0016-5085(23)00152.

  81. ZHOU C, Weng J, Liu C, Liu S, et al
    Disruption of SLFN11 deficiency-induced CCL2 signaling and macrophage M2 polarization potentiates anti-PD-1 therapy efficacy in hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 14:S0016-5085(23)00137.
    PubMed     Abstract available

  82. CHEN VL, Oliveri A, Miller MJ, Wijarnpreecha K, et al
    PNPLA3 genotype and diabetes identify patients with non-alcoholic fatty liver disease at high risk of incident cirrhosis.
    Gastroenterology. 2023 Feb 7:S0016-5085(23)00113.
    PubMed     Abstract available

  83. TOH MR, Wong Yi Ting E, Wong Hei S, Ng Wei Tian A, et al
    Global epidemiology and genetics of hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 2:S0016-5085(23)00105.
    PubMed     Abstract available

  84. UFERE NN, El-Jawahri A, Ritchie C, Lai JC, et al
    Promoting Prognostic Understanding and Health Equity for Patients With Advanced Liver Disease: Using "Best Case/Worst Case".
    Gastroenterology. 2023;164:171-176.

  85. PATEL AA, Arnold RM, Taddei TH, Woodrell CD, et al
    "Am I Going to Die?": Delivering Serious News to Patients With Liver Disease.
    Gastroenterology. 2023;164:177-181.

    A deCIDEdly New Germline Mutation That Protects Against Liver Disease.
    Gastroenterology. 2023;164:304-305.

  87. ZHU Y, Li X, He S
    Identification and Treatment of an Unusual Cause of Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:e17-e20.

    January 2023
  88. XIAO X, Yao D, Yang J
    An uncommon upper gastrointestinal bleeding.
    Gastroenterology. 2023 Jan 27:S0016-5085(23)00052.

  89. LIM M, Franses JW, Imperial R, Majeed U, et al
    EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma.
    Gastroenterology. 2023 Jan 25:S0016-5085(23)00056.

  90. WANG B, Bonkovsky HL, Lim JK, Balwani M, et al
    AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Gastroenterology. 2023 Jan 13:S0016-5085(22)01356.
    PubMed     Abstract available

  91. WONG GL, Hui VW, Yip TC, Lui GC, et al
    Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir.
    Gastroenterology. 2023;164:151-153.

  92. MITZLAFF K, Sayk F, Solbach P
    Jaundice and Weight Gain After Autologous Stem Cell Transplantation in a 28-Year-Old Patient With Diffuse Large B-Cell Lymphoma.
    Gastroenterology. 2023;164:32-33.

  93. SALIM Z, Laycock A, Hewavitharana C
    Abdominal Pain After Transarterial Chemoembolization.
    Gastroenterology. 2023;164:27-29.

    December 2022
  94. MO TT, Li M, Wang XY
    An Unusual Cause of Portal Hypertension.
    Gastroenterology. 2022 Dec 30:S0016-5085(22)01453.

  95. BLOCK PD, Farrell JJ, Li DK
    A Rare Cause of Gastrointestinal Bleeding after Pancreaticoduodenectomy.
    Gastroenterology. 2022 Dec 30:S0016-5085(22)01449.

  96. YEOH BS, Saha P, Golonka RM, Zou J, et al
    Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer.
    Gastroenterology. 2022;163:1658-1671.
    PubMed     Abstract available

  97. ZHU Y, Shi H, He S
    An Unusual Cause of Gastric Variceal Bleeding.
    Gastroenterology. 2022;163:1502-1504.

  98. ROBBINS J, El Hassan I, Siebenburgen C
    Evaluation and Treatment of GI Bleeding in a 51-Year-Old Man.
    Gastroenterology. 2022;163:1498-1501.

    November 2022
  99. OH AR, Jeong Y, Yu J, Minh Tam DT, et al
    Hepatocyte Kctd17 inhibition ameliorates glucose intolerance and hepatic steatosis caused by obesity-induced Chrebp stabilization.
    Gastroenterology. 2022 Nov 16:S0016-5085(22)01295.
    PubMed     Abstract available

  100. ZHANG H, Peng Y, Tang X
    Comments on "Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand".
    Gastroenterology. 2022 Nov 14. pii: S0016-5085(22)01271.

  101. WANG Z, Tai Y, Wu H
    A rare cause of abdominal pain after transjugular intrahepatic portosystemic shunt.
    Gastroenterology. 2022 Nov 10. pii: S0016-5085(22)01258.

  102. BRANDI G, Tovoli F, Tavolari S
    Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?
    Gastroenterology. 2022 Nov 4. pii: S0016-5085(22)01252.

  103. PRASOPPOKAKORN T, Rerknimitr R
    An Unusual Complication of Endoscopic Cyanoacrylate Injection for Gastric Varix.
    Gastroenterology. 2022;163:1186-1187.

  104. MAGAHIS P, Rosenblatt R, Mahadev S
    An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.
    Gastroenterology. 2022;163:e3-e5.

    October 2022
  105. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
    Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
    Gastroenterology. 2022 Oct 7. pii: S0016-5085(22)00721.
    PubMed     Abstract available

  106. BEHARI J
    Needle-free Nonalcoholic Fatty Liver Disease Prognostication: Moving One Step Closer.
    Gastroenterology. 2022;163:819-822.

  107. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
    Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
    Gastroenterology. 2022;163:1079-1089.
    PubMed     Abstract available

  108. SHINGINA A, Sarkar M, Feld L
    On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
    Gastroenterology. 2022;163:792-794.

  109. BAJAJ JS, Nagy LE
    Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
    Gastroenterology. 2022;163:840-851.
    PubMed     Abstract available

    September 2022
  110. LI H, Zheng J, Xu Q, Yang Y, et al
    Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.
    Gastroenterology. 2022 Sep 28. pii: S0016-5085(22)01085.
    PubMed     Abstract available

  111. DARA L
    No Necroptosis in Hepatocytes: The Final Nail in the Coffin?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01083.

  112. MURILLO PEREZ CF, Fisher H, Hiu S, Kareithi D, et al
    Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
    Gastroenterology. 2022 Sep 13. pii: S0016-5085(22)01060.
    PubMed     Abstract available

  113. HABER PK, Castet F, Torres-Martin M, Andreu-Oller C, et al
    Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
    Gastroenterology. 2022 Sep 12. pii: S0016-5085(22)01039.
    PubMed     Abstract available

  114. LONG MT, Noureddin M, Lim JK
    AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Gastroenterology. 2022;163:764-774.
    PubMed     Abstract available

  115. LEE BP, Terrault NA
    Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.
    Gastroenterology. 2022;163:539-542.

    August 2022
  116. PRESTON SP, Stutz MD, Allison CC, Nachbur U, et al
    Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies.
    Gastroenterology. 2022 Aug 26. pii: S0016-5085(22)01021.
    PubMed     Abstract available

  117. LIU J, Feng G
    A 41-year-old man with an abdominal mass and hepatomegaly.
    Gastroenterology. 2022 Aug 17. pii: S0016-5085(22)00957.

  118. D'ALESSIO A, Pinato DJ
    Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.

  119. DEBOSCH B
    Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.

  120. CLIFFORD C, Ryan R, Houlihan D
    An interesting case of hepatomegaly.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.

  121. LO GH
    The beauty and sorrow of using PPI in patients with cirrhosis.
    Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.

    Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2022;163:528-529.

  123. LE COSQUER G, Brunac AC, Peron JM
    An Unusual Case of Budd-Chiari Syndrome: Diagnosis and Treatment.
    Gastroenterology. 2022;163:e4-e5.

    July 2022
  124. BENHAMMOU JN, Rich NE, Cholankeril G, Zhang P, et al
    DETECT: Development of Technologies for Early HCC Detection.
    Gastroenterology. 2022;163:21-27.

  125. JAN J, Osho A, Murphy CC, Mazure CM, et al
    Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer.
    Gastroenterology. 2022;163:14-20.

  126. TERRAULT NA, Williamson C
    Pregnancy-Associated Liver Diseases.
    Gastroenterology. 2022;163:97-117.
    PubMed     Abstract available

  127. KARACHALIOU GS, Shi C, Abdelmalek MF
    Liver Mass: Thinking Out of the Box.
    Gastroenterology. 2022;163:e10-e12.

    June 2022
  128. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
    Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.

  129. BLAIR AB, Wang J, Davelaar J, Baker A, et al
    Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.
    Gastroenterology. 2022 Jun 16. pii: S0016-5085(22)00645.
    PubMed     Abstract available

  130. YING X, Rosenblatt R, Fortune BE
    Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States from 2014 to 2020.
    Gastroenterology. 2022 Jun 14. pii: S0016-5085(22)00647.

  131. DUURSMA SS, Verkade HJ, Bodewes FAJA
    Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
    Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.

  132. BAUER KC, Littlejohn PT, Ayala V, Creus-Cuadros A, et al
    Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.
    Gastroenterology. 2022;162:1858-1875.
    PubMed     Abstract available

  133. SULLIVAN S, Jirapinyo P, Kumbhari V
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2022;162:2131-2132.

    May 2022
  134. WANG J, Liu D, Chen S
    Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
    Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.

  135. NATSUI K, Maruyama M, Terai S
    Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?
    Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.

  136. HU S, Molina L, Tao J, Liu S, et al
    NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma.
    Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
    PubMed     Abstract available

  137. SINGH SP
    Proton pump inhibitor increasing the risk of infection and mortality in cirrhosis- need closer look!
    Gastroenterology. 2022 May 2. pii: S0016-5085(22)00458.

  138. DONNELLY MC, Stableforth W, Krag A, Reuben A, et al
    The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary.
    Gastroenterology. 2022;162:1561-1567.

  139. GOUDSMIT BFJ, Putter H, Van Hoek B
    The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
    Gastroenterology. 2022;162:1781-1782.

  140. GAN W, Liao B, Li X
    A Rare Cause of Liver Fibrosis in Adulthood.
    Gastroenterology. 2022;162:e1-e3.

    April 2022
    Effects of PPIs in cirrhotic patients: What do we really know?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.

  142. COPPS KD, Tao R
    A role for hepatic insulin signaling in alpha1-antitrypsin deficiency.
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00457.

  143. MAHMUD N, Serper M, Taddei TH, Kaplan DE, et al
    The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.
    Gastroenterology. 2022 Apr 6. pii: S0016-5085(22)00352.
    PubMed     Abstract available

  144. YANG Y, Ju C
    Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?
    Gastroenterology. 2022;162:1035-1037.

  145. XU P, Xi Y, Wang P, Luka Z, et al
    Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure.
    Gastroenterology. 2022;162:1226-1241.
    PubMed     Abstract available

  146. QIAN T, Fujiwara N, Koneru B, Ono A, et al
    Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
    Gastroenterology. 2022;162:1210-1225.
    PubMed     Abstract available

    March 2022
  147. RUDNICK DA, Huang J, Hidvegi T, Chu AS, et al
    Regulation of PGC1alpha downstream of the insulin signaling pathway plays a role in the hepatic proteotoxicity of mutant alpha1-antitrypsin deficiency variant Z.
    Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00261.
    PubMed     Abstract available

  148. VELENOSI TJ, Ben-Yakov G, Podszun MC, Hercun J, et al
    Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease.
    Gastroenterology. 2022 Mar 10. pii: S0016-5085(22)00235.
    PubMed     Abstract available

  149. ALTAYAR O, Shah R, Chang CY, Falck-Ytter Y, et al
    AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:937-951.

  150. SU GL, Altayar O, O'Shea R, Shah R, et al
    AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:920-934.
    PubMed     Abstract available

  151. MAYDEO A, Patil G
    How to Approach a Patient With Gastric Varices.
    Gastroenterology. 2022;162:689-695.

    February 2022
  152. CHENG N, Ren Y, Zhou J, Zhang Y, et al
    Deep learning-based classification of hepatocellular nodular lesions on whole-slide histopathologic images.
    Gastroenterology. 2022 Feb 21. pii: S0016-5085(22)00155.
    PubMed     Abstract available

  153. CARRIQUE L, Lynch J, Selzner N
    We thank Bekki et al and Bhagat et al for their comments on our article "Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse". Bekki et al pointed out a trend toward inferior graft su
    Gastroenterology. 2022 Feb 3. pii: S0016-5085(22)00103.

  154. STRAZZABOSCO M, Cabibbo G, Colombo M
    Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future.
    Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00090.

  155. KANNEGANTI M, Singal AG
    Gastroenterology. 2022 Feb 1. pii: S0016-5085(22)00092.
    PubMed     Abstract available

  156. LEE SK, Wong JC, Ng JJ
    An Uncommon Cause of Hematemesis in a Patient With End-stage Renal Disease.
    Gastroenterology. 2022;162:404-405.

  157. TAI Y, Wang Z, Wu H
    An Unusual Cause of Isolated Gastric Varices.
    Gastroenterology. 2022;162:e4-e6.

  158. QU C, Wang HY, Xiu DR
    A Rare Liver Tumor Nodule.
    Gastroenterology. 2022;162:e1-e3.

    January 2022
  159. WILLIAMS R, White PM, Balzora S
    "A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology".
    Gastroenterology. 2022 Jan 21. pii: S0016-5085(22)00035.

  160. WILSON SR, Duncan AW
    Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution.
    Gastroenterology. 2022;162:46-48.

    December 2021
  161. YANG AH, Gandhi S, Urrunaga NH
    Liver Tumor post Liver Transplantation for Hepatitis C Cirrhosis: An Unusual Cause.
    Gastroenterology. 2021 Dec 26. pii: S0016-5085(21)04161.

  162. FORNER A, Colombo M
    The maze of systemic therapy for hepatocellular carcinoma: did we find the compass?
    Gastroenterology. 2021 Dec 23. pii: S0016-5085(21)04121.

    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03811.

  164. GERMAN MN, Brown R, Lucey MR
    Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease.
    Gastroenterology. 2021;161:1795-1797.

  165. POLLO-FLORES P, Trebicka J
    Statins After Variceal Bleeding Are Beneficial, but Still an Unexplained Mystery?
    Gastroenterology. 2021;161:2067-2068.

  166. BARRITT AS 4TH, Moon AM
    Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease-Effective Intervention for a Select Few.
    Gastroenterology. 2021;161:2063-2064.

  167. RAMAI D, Facciorusso A
    Liver Cancer Reduction After Bariatric Surgery: Time to Expand Its Indication?
    Gastroenterology. 2021;161:2063.

  168. KIM WR, Mannalithara A, Heimbach JK, Kamath PS, et al
    MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Gastroenterology. 2021;161:1887-1895.
    PubMed     Abstract available

  169. SACK JS, Patel RS, Ahmad J
    Nausea and Vomiting 8 Months After Liver Transplantation.
    Gastroenterology. 2021;161:e12-e14.

    November 2021
  170. LOOMBA R, Ratziu V, Harrison SA
    Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2021 Nov 22. pii: S0016-5085(21)03795.

  171. BHAGAT N, Rathi S, Singh V
    Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse.
    Gastroenterology. 2021 Nov 5. pii: S0016-5085(21)03724.

  172. KANWAL F, Shubrook JH, Adams LA, Pfotenhauer K, et al
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:1657-1669.
    PubMed     Abstract available

  173. WANG X, Cheng Z
    Nodules on the Lower Legs With Ankle Joint Pain.
    Gastroenterology. 2021;161:1390-1392.

  174. VARGAS JF, Arab JP
    Pulsatile Epigastric Mass and Liver Masses in a 38-Year-Old Patient With Splenomegaly Since Childhood.
    Gastroenterology. 2021;161:e14-e16.

    October 2021
  175. LEE TH, Roper J, King L
    Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
    PubMed     Abstract available

  176. LIU N, Chang CW, Steer CJ, Wang XW, et al
    MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03652.
    PubMed     Abstract available

  177. PEERY AF, Crockett SD, Murphy CC, Jensen ET, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03655.
    PubMed     Abstract available

  178. LOUISSAINT J, Gibbs JT, Lok AS, Tapper EB, et al
    Strategies to Improve Video Visit Use in Persons With Liver Disease.
    Gastroenterology. 2021;161:1080-1084.

    September 2021
  179. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
    AGA Technical Review on Coagulation in Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.

  180. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
    AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.

  181. DREYER SB, Upstill-Goddard R, Legrini A, Biankin AV, et al
    Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03522.

  182. BEKKI Y, Fenig Y
    Evaluation of Early Liver Transplantation for Alcohol-Related Cirrhosis.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03491.

  183. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.
    Gastroenterology. 2021 Sep 3. pii: S0016-5085(21)03335.

  184. GUO L, Yi X, Chen L, Zhang T, et al
    Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma.
    Gastroenterology. 2021 Sep 2. pii: S0016-5085(21)03471.
    PubMed     Abstract available

  185. KANWAL F, Shubrook JH, Younossi Z, Natarajan Y, et al
    Preparing for the NASH Epidemic: A Call to Action.
    Gastroenterology. 2021;161:1030-1042.
    PubMed     Abstract available

  186. HABER PK, Puigvehi M, Castet F, Lourdusamy V, et al
    Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
    Gastroenterology. 2021;161:879-898.
    PubMed     Abstract available

    A Visual Engram Worth Remembering.
    Gastroenterology. 2021;161:809-810.

  188. FUCHS A, Samovski D, Smith GI, Cifarelli V, et al
    Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:968-981.
    PubMed     Abstract available

    August 2021
  189. BALZORA S, May FP, Ogedegbe G
    COVID-19 and Social Determinants of Health in Gastroenterology and Hepatology.
    Gastroenterology. 2021 Aug 26. pii: S0016-5085(21)03438.

  190. SU F
    COVID-19 and cirrhosis: a combination we must strive to prevent.
    Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.

  191. AZZIMATO V, Chen P, Barreby E, Morgantini C, et al
    Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03410.
    PubMed     Abstract available

  192. OLYNYK JK, Ramm GA
    Gastroenterology. 2021 Aug 19. pii: S0016-5085(21)03405.
    PubMed     Abstract available

  193. TAI CS, Ni YH, Lee PI
    An Unusual Case with a Huge Hepatic Cystic Mass.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03357.

  194. CARRIQUE L, Quance J, Tan A, Abbey S, et al
    Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
    Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
    PubMed     Abstract available

  195. GOUGH NR, Xiang X, Mishra L
    TGF-beta Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer.
    Gastroenterology. 2021;161:434-452.
    PubMed     Abstract available

    July 2021
  196. MEHTA N, Frenette C, Tabrizian P, Hoteit M, et al
    Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Gastroenterology. 2021 Jul 28. pii: S0016-5085(21)03284.
    PubMed     Abstract available

  197. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
    TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
    PubMed     Abstract available

  198. GE J, Pletcher MJ, Lai JC
    Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
    PubMed     Abstract available

  199. YE P, Miao H, Chen Y
    An unusual case of symptomatic portal hypertension.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.

  200. MAAN R, Darwish Murad S, van der Meer AJ
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:371-372.

  201. LI L, Liu C, Qi X
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:370-371.

  202. PARIKH ND, Chung GS, Mellinger J, Blanchette JG, et al
    Alcohol Policies and Alcohol-related Liver Disease Mortality.
    Gastroenterology. 2021;161:350-352.

  203. RUSTGI VK, Li Y, Gupta K, Minacapelli CD, et al
    Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.
    Gastroenterology. 2021;161:171-184.
    PubMed     Abstract available

  204. SURAPANENI PK, Mills K, Renelus BD
    A Rare Complication of Sickle Cell Anemia.
    Gastroenterology. 2021;161:45-46.

    June 2021
  205. CHIANG HC, Chien SC, Lin YJ
    Pleural effusion with gastric ulcer.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03176.

  206. TSOI AH, Garg M, Tsoi EH
    Peptic ulcer disease: an unusual presentation of a common problem.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03174.

  207. VALENTI L, Mondelli M, Colombo M
    Liver field during immunotherapy of hepatocellular carcinoma: some like it hot.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03165.

  208. LI H, Liu H
    Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
    Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.

  209. MEDICI V
    Expanding the Diagnostic Toolkit of Wilson Disease with ATP7B Peptides.
    Gastroenterology. 2021;160:2249-2251.

  210. SU P, Hong J, Li T
    An Uncommon Lesion of the Liver.
    Gastroenterology. 2021;160:2258-2260.

  211. COLLINS CJ, Yi F, Dayuha R, Duong P, et al
    Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.
    Gastroenterology. 2021;160:2367-2382.
    PubMed     Abstract available

    May 2021
  212. EDWARDS LA, Goldenberg SD, Shawcross DL
    Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.

  213. GARCIA-TSAO G, Abraldes JG
    Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
    Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.

  214. PERRY IE, Azam MU, Yap JE
    Carcinoma Camouflage.
    Gastroenterology. 2021;160:1940-1942.

  215. SHEN C, Zong Z, Xu N
    "Malignant" Liver Cysts Cause Liver Failure and Recurrence.
    Gastroenterology. 2021;160:e7-e9.

  216. NAYAK LJ, Sondhi AR, Westerhoff M
    Gastroenterology. 2021;160:e5-e6.

  217. HA NB, Wang CW, El-Nachef N
    An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.
    Gastroenterology. 2021;160:e1-e4.

    April 2021
  218. PACK M
    Model Organisms Help Define the ABCs of Neonatal Cholestasis.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00636.

  219. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
    Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
    Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
    PubMed     Abstract available

  220. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.

  221. PONZIANI FR, Nesci A, Del Zompo F, Santopaolo F, et al
    Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection.
    Gastroenterology. 2021;160:1891-1893.

  222. KHAN MU, Mushtaq K, Alkaabi SR
    Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease.
    Gastroenterology. 2021;160:1894-1895.

  223. VERMA N, Duseja A, Singh V
    Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease.
    Gastroenterology. 2021;160:1893-1894.

  224. LUUKKONEN PK, Salomaa V, Aberg F
    The Pi *MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.
    Gastroenterology. 2021;160:1874-1875.

  225. JAMIALAHMADI O, Mancina RM, Ciociola E, Tavaglione F, et al
    Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
    Gastroenterology. 2021;160:1634-1646.
    PubMed     Abstract available

    March 2021
  226. ASSELTA R, Paraboschi EM, Gerussi A, Cordell HJ, et al
    X chromosome contribution to the genetic architecture of primary biliary cholangitis.
    Gastroenterology. 2021 Mar 3. pii: S0016-5085(21)00466.
    PubMed     Abstract available

  227. CASADEI-GARDINI A, Cascinu S, Colombo M
    Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
    Gastroenterology. 2021;160:1423-1424.

  228. GOLDBERG D, Ross-Driscoll K, Lynch R
    County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
    Gastroenterology. 2021;160:1140-1150.
    PubMed     Abstract available

  229. KOBAYASHI H, Gieniec KA, Wright JA, Wang T, et al
    The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Gastroenterology. 2021;160:1224-1239.
    PubMed     Abstract available

  230. PRZYBYSZEWSKI EM, Deshpande V, Uchida AM
    An Unsuspected Cause of Rectal Bleeding.
    Gastroenterology. 2021;160:e1-e2.

    February 2021
  231. YOUNOSSI ZM, Corey KE, Lim JK
    AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2021;160:912-918.
    PubMed     Abstract available

  232. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
    High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Gastroenterology. 2021;160:831-846.
    PubMed     Abstract available

  233. NASSANI N, Melitas C, Villa E
    An Unusual Cause of Watery Diarrhea.
    Gastroenterology. 2021;160:671-674.

    January 2021
  234. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
    How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
    Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.

  235. ACHARYA C, Bajaj JS
    Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
    Gastroenterology. 2021;160:556-572.
    PubMed     Abstract available

  236. NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
    Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;160:193-205.
    PubMed     Abstract available

    December 2020
  237. VAN DIJK M, Weehuizen TAF, Lowenberg M
    A rare cause of acute abdominal pain after endoscopic retrograde cholangiopancreaticography.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35559.

  238. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
    Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
    Gastroenterology. 2020;159:2232-2234.

    November 2020
  239. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
    Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
    Gastroenterology. 2020;159:1985-1987.

  240. XANTHAKOS SA, Lavine JE, Yates KP, Schwimmer JB, et al
    Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Gastroenterology. 2020;159:1731-1751.
    PubMed     Abstract available

  241. LANG S, Demir M, Martin A, Jiang L, et al
    Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;159:1839-1852.
    PubMed     Abstract available

    October 2020
  242. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
    Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
    Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
    PubMed     Abstract available

  243. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
    AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
    PubMed     Abstract available

  244. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
    Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
    PubMed     Abstract available

  245. DE VRIES E, Bolier R, Goet J, Pares A, et al
    Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
    Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
    PubMed     Abstract available

  246. ROMEO S
    MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
    Gastroenterology. 2020;159:1231-1232.

  247. RAMLI MNB, Lim YS, Koe CT, Demircioglu D, et al
    Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
    Gastroenterology. 2020;159:1471-1486.
    PubMed     Abstract available

    September 2020
  248. VILAR-GOMEZ E, Sookoian S, Pirola CJ, Liang T, et al
    ADH1B *2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
    Gastroenterology. 2020;159:929-943.
    PubMed     Abstract available

  249. CHAI C, Cox B, Yaish D, Gross D, et al
    Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Gastroenterology. 2020;159:999-1014.
    PubMed     Abstract available

  250. WANG Y, Pan Y, Zhou Z
    An Unusual Cause of Fever in a Man With a Liver Mass.
    Gastroenterology. 2020;159:842-844.

    August 2020
  251. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.

  252. NABI O, Lacombe K, Boursier J, Mathurin P, et al
    Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Gastroenterology. 2020;159:791-793.

  253. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
    Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
    Gastroenterology. 2020;159:534-548.
    PubMed     Abstract available

  254. GUPTA V, Gupta I, Park J, Bram Y, et al
    Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
    Gastroenterology. 2020;159:624-638.
    PubMed     Abstract available

  255. NAUDIN CR, Maner-Smith K, Owens JA, Wynn GM, et al
    Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
    Gastroenterology. 2020;159:639-651.
    PubMed     Abstract available

    June 2020
  256. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.